{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T20:10:39Z","timestamp":1687291839047},"reference-count":49,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.jgyn.2007.06.005","type":"journal-article","created":{"date-parts":[[2012,2,27]],"date-time":"2012-02-27T12:16:38Z","timestamp":1330344998000},"page":"631-641","source":"Crossref","is-referenced-by-count":1,"title":["Vaccination prophylactique et\u00a0th\u00e9rapeutique contre\u00a0le\u00a0papillomavirus humain"],"prefix":"10.1016","volume":"36","author":[{"given":"J.-L.","family":"Brun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Riethmuller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jgyn.2007.06.005_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3322\/canjclin.49.1.33","article-title":"Global cancer statistics","volume":"49","author":"Parkin","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jgyn.2007.06.005_bib2","series-title":"\u00c9volution de l\u2019incidence et de la mortalit\u00e9 par cancer en France de 1978 \u00e0 2000","first-page":"107","article-title":"Col de l\u2019ut\u00e9rus","author":"Exbrayat","year":"2003"},{"key":"10.1016\/j.jgyn.2007.06.005_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1136\/jcp.54.3.163","article-title":"Papillomavirus research update: highlights of the Barcelona HPV 2000 international papillomavirus conference","volume":"54","author":"Bosch","year":"2001","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","article-title":"Against which human papillomavirus types shall we vaccinate and screen? The international perspective","volume":"111","author":"Munoz","year":"2004","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jgyn.2007.06.005_bib6","first-page":"1063","article-title":"Risk factors for invasive cervical cancer among Latinas and non-Latinas in Los Angeles County","volume":"77","author":"Peters","year":"1986","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jgyn.2007.06.005_bib7","first-page":"1365","article-title":"Papillomavirus humains et carcinogen\u00e8se du col ut\u00e9rin: perspectives dans les domaines du d\u00e9pistage et de la pr\u00e9vention","volume":"181","author":"Orth","year":"1997","journal-title":"Bull. Acad. Natl. Med."},{"key":"10.1016\/j.jgyn.2007.06.005_bib8","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00007435-199017010-00004","article-title":"Prevalence, incidence, and estimated life-time risk of cervical human papillomavirus infections in a nonselected Finnish female population","volume":"17","author":"Syrjanen","year":"1990","journal-title":"Sex. Transm. Dis."},{"key":"10.1016\/j.jgyn.2007.06.005_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJM199802123380703","article-title":"Natural history of cervicovaginal papillomavirus infection in young women","volume":"338","author":"Ho","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jgyn.2007.06.005_bib10","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/00004347-199304000-00018","article-title":"Natural history of cervical intraepithelial neoplasia: a critical review","volume":"12","author":"Ostor","year":"1993","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib11","series-title":"Human papillomavirus infection: a clinical atlas","first-page":"1","article-title":"Papillomaviruses in human pathology: epidemiology, pathogenesis and oncogenic role","author":"Wieland","year":"1997"},{"key":"10.1016\/j.jgyn.2007.06.005_bib12","first-page":"731","article-title":"Comparaison co\u00fbt\u2013efficacit\u00e9 par mod\u00e9lisation de l\u2019imiquimod et de la podophyllotoxine dans le traitement du condylome acumin\u00e9 externe en France","volume":"130","author":"Lafuma","year":"2003","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib13","first-page":"991","article-title":"Incidence et prise en charge des condylomes acumin\u00e9s externes en m\u00e9decine g\u00e9n\u00e9rale","volume":"129","author":"Lukasiewicz","year":"2002","journal-title":"Ann. Dermatol. Venereol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib14","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1128\/JVI.67.1.315-322.1993","article-title":"Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins","volume":"67","author":"Hagensee","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib15","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1099\/0022-1317-75-8-2075","article-title":"Human papillomavirus (HPV) type 11 recombinant virus-like particles induce the formation of neutralizing antibodies and detect HPV-specific antibodies in human sera","volume":"75","author":"Rose","year":"1994","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib16","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1006\/scbi.1996.0046","article-title":"Papillomavirus-like particles and HPV vaccine development","volume":"7","author":"Schiller","year":"1996","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.jgyn.2007.06.005_bib18","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1056\/NEJMoa020586","article-title":"Proof of Principle Study Investigators. A controlled trial of a human papillomavirus type 16 vaccine","volume":"347","author":"Koutsky","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jgyn.2007.06.005_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.AOG.0000192397.41191.fb","article-title":"Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial","volume":"107","author":"Mao","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib20","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","article-title":"Efficacy of a bivalent L1 virus-like particle vaccine in prevention of infection with human papillomavirus types 16 and 18 in young women: a randomised controlled trial","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.06.005_bib21","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(06)68439-0","article-title":"Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial","volume":"367","author":"Harper","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.06.005_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","article-title":"Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib23","doi-asserted-by":"crossref","first-page":"5571","DOI":"10.1016\/j.vaccine.2006.04.068","article-title":"Immunologic responses following administration of a vaccine targeting human papillomavirus types 6, 11, 16, and 18","volume":"24","author":"Villa","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jgyn.2007.06.005_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.vaccine.2004.06.006","article-title":"Safety and immunogenicity profile of an experimental hepatitis B vaccine adjuvanted with AS04","volume":"23","author":"Boland","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jgyn.2007.06.005_bib25","first-page":"3406","article-title":"A phase I trial of a human papillomavirus (HPV) peptide vaccine for women with high-grade cervical and vulvar intraepithelial neoplasia who are HPV-16 positive","volume":"6","author":"Muderspach","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jgyn.2007.06.005_bib26","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0959-8049(99)00048-9","article-title":"Vaccination with HPV-16 peptides of patients with advanced cervical carcinoma: clinical evaluation of a phase I-II trial","volume":"35","author":"Van Driel","year":"1999","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.jgyn.2007.06.005_bib27","first-page":"2103","article-title":"Cell-mediated immunological responses in cervical and vaginal cancer patients immunized with a lipidated epitope of human papillomavirus type 16E7","volume":"4","author":"Steller","year":"1998","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jgyn.2007.06.005_bib28","series-title":"Preliminary results of HPV-16 long peptide vaccination in patients with HPV induced genital lesion: safety, immunogenicity and clinical effect. Proceedings of the 23rd international papillomavirus conference and clinical workshop. Prague","author":"Kenter","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib29","author":"Daftarian","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib30","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s10350-004-6229-6","article-title":"Activity of HspE7, a novel immunotherapy, in patients with anogenital warts","volume":"45","author":"Goldstone","year":"2002","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.jgyn.2007.06.005_bib31","series-title":"Potent CD8T cell responses against HPV-16 E7 antigen: augmenting the anti-HSPE7 immune response with poly ICLC or CPG. Proceedings of the 23rd international papillomavirus conference and clinical workshop. Prague","author":"Webb","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.vaccine.2004.05.013","article-title":"Phase 1 study of HPV-16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX\u2122 adjuvant in women with cervical intraepithelial neoplasia","volume":"23","author":"Frazer","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.jgyn.2007.06.005_bib33","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1158\/0008-5472.641.65.2","article-title":"Eradication of established tumors by vaccination with recombinant Bordetella pertussis adenylate cyclase carrying the human papillomavirus 16 E7 oncoprotein","volume":"65","author":"Pr\u00e9ville","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.jgyn.2007.06.005_bib34","first-page":"3676","article-title":"Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus HPV-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer","volume":"8","author":"Kaufmann","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jgyn.2007.06.005_bib35","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1016\/S0140-6736(96)90674-1","article-title":"A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins, as immunotherapy for cervical cancer","volume":"347","author":"Borysiewicz","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/j.jgyn.2007.06.005_bib36","doi-asserted-by":"crossref","first-page":"271","DOI":"10.2515\/therapie:2005035","article-title":"Vaccination anti-papillomavirus humains","volume":"60","author":"Bourgault-Villada","year":"2005","journal-title":"Therapie"},{"key":"10.1016\/j.jgyn.2007.06.005_bib37","series-title":"Twelve month follow-up data of the HPV-16 CIN2\/3 women having responded to Transgene\u2019s therapeutic vaccine TG4001. Proceedings of the 23rd international papillomavirus conference and clinical workshop. Prague","author":"Brun","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib38","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s002620000125","article-title":"A recombinant vaccinia virus containing the papilloma E2 protein promotes tumor regression by stimulating macrophage antibody-dependent cytotoxicity","volume":"49","author":"Rosales","year":"2000","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jgyn.2007.06.005_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/10430340460745757","article-title":"Therapeutic vaccination with MVA E2 can eliminate precancerous lesions (CIN 1, CIN 2, and CIN 3) associated with infection by oncogenic human papillomavirus","volume":"15","author":"Corona-Gutierrez","year":"2004","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.jgyn.2007.06.005_bib40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.cgt.7700937","article-title":"Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine","volume":"13","author":"Garcia-Hernandez","year":"2006","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.jgyn.2007.06.005_bib41","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1067\/mob.2003.256","article-title":"Immunotherapy of human cervical high-grade intraepithelial neoplasia with microparticle-delivered human papillomavirus 16E7 plasmid DNA","volume":"188","author":"Sheets","year":"2003","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib42","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/01.AOG.0000110246.93627.17","article-title":"ZYC101a for treatment of high-grade cervical intraepithelial neoplasia: a randomized controlled trial","volume":"103","author":"Garcia","year":"2004","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib43","series-title":"Follow-up HPV status in subjects who underwent LEEP during a trial evaluating the efficacy and safety of amolimogene (ZYC101a). Proceedings of the 23rd international papillomavirus conference and clinical workshop. Prague","author":"Bua","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00432-003-0463-5","article-title":"Dendritic cell-based tumor vaccine for cervical cancer II: results of a clinical pilot study in 15 individual patients","volume":"129","author":"Ferrara","year":"2003","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib45","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.ygyno.2005.09.040","article-title":"HPV-16\/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities","volume":"10","author":"Santin","year":"2006","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.jgyn.2007.06.005_bib46","series-title":"Effect of a HPV-16\/18 vaccine on resolution of infections in women with pre-existing HPV. Proceedings of the 23rd international papillomavirus conference and clinical workshop. Prague","author":"Hildesheim","year":"2006"},{"key":"10.1016\/j.jgyn.2007.06.005_bib47","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1002\/ijc.21781","article-title":"Combined prophylactic and therapeutic cancer vaccine: enhancing CTL responses to HPV-16 E2 using a chimeric VLP in HLA-A2 mice","volume":"118","author":"Qian","year":"2006","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.jgyn.2007.06.005_bib48","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1158\/1078-0432.CCR-04-2599","article-title":"Spontaneous regression of high-grade cervical dysplasia: effects of human papillomavirus type and HLA phenotype","volume":"11","author":"Trimble","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jgyn.2007.06.005_bib49","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S0140-6736(06)68181-6","article-title":"Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical leions: systematic review and meta-analysis","volume":"367","author":"Kyrgiou","year":"2006","journal-title":"Lancet"}],"container-title":["Journal de Gyn\u00e9cologie Obst\u00e9trique et Biologie de la Reproduction"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0368231507002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,20]],"date-time":"2023-06-20T19:53:52Z","timestamp":1687290832000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0368231507002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":49,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0368231507002426"],"URL":"https:\/\/doi.org\/10.1016\/j.jgyn.2007.06.005","relation":{},"ISSN":["0368-2315"],"issn-type":[{"value":"0368-2315","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}